COST-EFFECTIVENESS OF EPISODIC OR MAINTENANCE INFLIXIMAB VERSUS STANDARD TREATMENT IN AN INCIDENCE COHORT OF CROHN'S DISEASE PATIENTS WITH 10-YEARS FOLLOW-UP

被引：0
|
作者：
Odes, S. [1 ]
Greenberg, D. [2 ]
Vardi, H. [2 ]
Friger, M. [2 ]
Stockbrugger, R. [3 ]
Munkholm, P. [4 ,5 ]
机构：
[1] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel
[3] Univ Hosp Maastricht, Maastricht, Netherlands
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Herlev Hosp, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.772
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A329 / A330
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness of Episodic or Maintenance Infliximab Treatment Versus Standard Treatment in a Community-Based Incidence Cohort of Adult Ulcerative Colitis Patients With 10-Years Follow-up
    Odes, Selwyn H.
    Vardi, Hillel
    Greenberg, Dan
    Friger, Michael
    Stockbrugger, Reinhold W.
    O'Morain, Colm A.
    Tsianos, Epameinondas V.
    Politi, Patrizia
    Clofent, Juan
    Moum, Bjorn
    Freitas, Joao
    Langholz, Ebbe
    Munkholm, Pia S.
    GASTROENTEROLOGY, 2012, 142 (05) : S256 - S256
  • [2] Cost-Effectiveness of Scheduled Maintenance Treatment with Infliximab for Pediatric Crohn's Disease
    Punekar, Yogesh Suresh
    Sunderland, Thomas
    Hawkins, Neil
    Lindsay, James
    VALUE IN HEALTH, 2010, 13 (02) : 188 - 195
  • [3] The cost effectiveness of scheduled maintenance treatment with infliximab among patients with crohn's disease
    Lindsay, J.
    Punekar, Y.
    Abhyankar, B.
    Chung-Faye, G.
    GUT, 2008, 57 : A145 - A145
  • [4] Incidence and Importance of Antibody Responses to Infliximab After Maintenance or Episodic Treatment in Crohn's Disease
    Hanauer, Stephen B.
    Wagner, Carrie L.
    Bala, Mohan
    Mayer, Lloyd
    Travers, Suzanne
    Diamond, Robert H.
    Olson, Allan
    Bao, Warren
    Rutgeerts, Paul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (07) : 542 - 553
  • [5] RADIATION-ASSOCIATED DISEASE - DISEASE INCIDENCE AND COST-EFFECTIVENESS OF FOLLOW-UP
    SCHRAMM, VL
    CARROLL, RG
    LARYNGOSCOPE, 1979, 89 (04): : 529 - 537
  • [6] Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
    Loftus, Edward V., Jr.
    Johnson, Scott J.
    Yu, Andrew P.
    Wu, Eric Q.
    Chao, Jingdong
    Mulani, Parvez M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1302 - 1309
  • [7] THE COST EFFECTIVENESS OF SCHEDULED MAINTENANCE TREATMENT WITH INFLIXIMAB AMONG PAEDIATRIC PATIENTS WITH CROHN'S DISEASE IN SCOTLAND
    Punekar, Y. S.
    Sunderland, T.
    Morris, J.
    VALUE IN HEALTH, 2008, 11 (06) : A423 - A423
  • [8] Effectiveness and Tolerability of Maintenance Methotrexate Therapy in Crohn's Disease Patients; Analysis of a Referral Hospital-Based 10-Years Intercept Cohort
    Seinen, Margien L.
    de Boer, Nanne K.
    Mulder, Chris J.
    Bouma, Gerd
    van Bodegraven, Adriaan A.
    GASTROENTEROLOGY, 2011, 140 (05) : S280 - S280
  • [9] Maintenance of Clinical Benefit in Crohn's Disease Patients After Discontinuation of Infliximab: Long Term Follow-up of a Single Center Cohort
    Waugh, Alistair W.
    Wong, Karen
    Fedorak, Richard N.
    GASTROENTEROLOGY, 2010, 138 (05) : S685 - S685
  • [10] Is scheduled maintenance treatment with infliximab cost effective in patients with Crohn's disease?
    Lindsay, James O.
    Punekar, Yogesh
    Morris, James
    Chung-Faye, Guy
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB318 - AB318
12345